LCMS Bioanalysis of Antibody Drugs Using Fab-selective Proteolysis “nSMOL Method” — Selection of Signature Peptide —

C10G-E054 Solutions for Biopharmaceutical Application Notebook First Edition: December, 2017 © Shimadzu Corporation, 2017 Solutions for Biopharmaceutical Index Application Notebook Bioanalysis LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis nSMOL, which enables selective proteolysis of the…

IMPROVE SPEED AND ACCURACY OF MONOCLONAL ANTIBODY BIOANALYSIS USING NANOTECHNOLOGY AND LCMS As scientists gain an advanced understanding of diseases at the molecular level, the biopharmaceutical industry is significantly increasing research, production and manufacturing of monoclonal antibodies (mAbs). In fact,…

LC/MS nSMOL and Liquid Chromatography Mass Spectrometry LC-31-ADI-54 Bioanalytical assessment of Cetuximab in Wistar rat plasma using nSMOL and LCMS-8060 ■ Introduction Cetuximab is a human monoclonal antibody (mAb) for the treatment of metastatic colorectal carcinoma, head and neck cancer.…

LAAN-A-LM-E117A Application News No. C146A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis - „ nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that enables…